Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2020 Earnings Conference Call February 17, 2021 8:30 AM ET Company Participants Meredith Kaya - VP, IR and Corporate Communications Mark Mallon - CEO Thomas McCourt - President Gina Consylman - SVP and CFO Michael Shetzline - CMO, SVP and Head of Drug Development Conference Call Participants Unidentified Analyst - Credit Suisse Eric Joseph - J.P. Morgan Boris Peaker - Cowen and Company Jacob Hughes - Wells Fargo Operator Ladies and gentlemen, thank you for sta ...